The Samsung Biologics union will initiate a second strike starting November 6, with approximately 400 members participating. The union plans to expand its fair strike actions gradually while adhering to a court's provisional decision.
On November 4, the Samsung Biologics Win-Win Labor Union announced, "The company has not responded to our negotiations," stating that the second strike will commence at midnight on November 6 and continue until November 27. The expected participation is around 400 members.
The strike will target the Quality Control (QC) testing department, the Quality Assurance (QA) department, the logistics department, and indirect support roles in production. The union emphasized, "We remain open to negotiations even during the dispute process."
Samsung Biologics responded, saying, "We remain committed to reaching an agreement through negotiations," and pledged to do their utmost to maintain fair operations and quality stability. However, they cautioned that if the strike escalates, constructive dialogue and agreement may become difficult. They added, "We will do our best to ensure that patients and clients are not adversely affected while maintaining fair operations and quality stability."
On November 4, the Samsung Biologics Win-Win Labor Union announced, "The company has not responded to our negotiations," stating that the second strike will commence at midnight on November 6 and continue until November 27. The expected participation is around 400 members.
The strike will target the Quality Control (QC) testing department, the Quality Assurance (QA) department, the logistics department, and indirect support roles in production. The union emphasized, "We remain open to negotiations even during the dispute process."
Samsung Biologics responded, saying, "We remain committed to reaching an agreement through negotiations," and pledged to do their utmost to maintain fair operations and quality stability. However, they cautioned that if the strike escalates, constructive dialogue and agreement may become difficult. They added, "We will do our best to ensure that patients and clients are not adversely affected while maintaining fair operations and quality stability."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.